- Investing Ideas
- Belgian Pharmaceuticals & Biotech Stable Growth Stocks
Belgian Pharmaceuticals & Biotech Stable Growth Stocks
Results
2
0 new
2 companies
UCB
Market Cap: €49.3b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€250.00
7D
-4.7%
1Y
58.1%
argenx
Market Cap: €47.3b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€755.80
7D
-0.3%
1Y
59.9%